News
On a quest to bring its multiple myeloma antibody-drug conjugate Blenrep back to the U.S. | Members of the FDA's Oncologic ...
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
In a surprise, a FDA advisory panel voted that risks tied to a GSK blood cancer drug called Blenrep outweighed the benefits ...
The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
GSK plc (NYSE:GSK) is one of the best cheap stocks under $50 to buy now. On July 15, BofA analyst Sachin Jain maintained a ...
The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...
The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback